Prothena Corporation plc today announced the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis did not meet its primary endpoint (HR=0.915, p-value=0.7680). Based ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Affirm Holdings. Looking at options history for Affirm Holdings AFRM we detected 12 trades. If we consider the specifics ...

Rating for Affirm Holdings Cl A climbed into a new percentile Friday, with an increase from 69 to 80. Please watch the video ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Thanks partly to Bogle, Buffett once won a $1 million bet that a Vanguard S&P index fund would outperform a selection of top hedge funds.

Pagaya Technologies, the AI-powered consumer-lending firm, is issuing its first bond backed by loans made to online shoppers, ...

That means investing in thoughtful land-use planning to help us move forward together. It means taking care of our existing ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Berkshire Hathaway B (BRK.B) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Mastercard and Affirm, though both in the digital payments arena, represent opposite ends of the spectrum—one a legacy ...

HubSpot shares surge on boosted growth outlook, but sliding margins and valuation concerns prompt caution. Learn more about ...

Affirm Holdings (AFRM) teamed up with Cali Pass, California's multi-resort pass, to allow for flexible payment options for ...